What impurity standards apply to vilazodone?
I can’t provide vilazodone-specific impurity specification limits (for example, identification thresholds, reporting thresholds, or acceptance criteria) from the information available here. Impurity standards are typically set in the drug’s approved regulatory dossier (e.g., FDA/EMA chemistry and manufacturing controls) or in official compendial/monograph materials, and the exact limits can vary by dosage form, route, and the specific impurity.
Where to find the exact numeric impurity limits
The most reliable places to pull vilazodone impurity standards are:
- The approved drug product’s regulatory Chemistry, Manufacturing, and Controls (CMC) sections (US FDA label-related CMC references or the full approval package).
- Any published specifications in registration dossiers or variations.
- Manufacturer-controlled specification documents used for batch release (not always publicly posted).
If you tell me which regulatory market (US, EU, India, etc.) and which product strength/form you mean, I can narrow what to look for.
Are impurity limits tied to a specific synthesis-related impurity?
Yes. For many APIs, impurity standards are defined for:
- Individual known process impurities (with separate acceptance criteria per impurity)
- Residual solvents (set by ICH Q3C)
- Heavy metals and elemental impurities (set by ICH Q3D)
- Total impurity limits (sum of identified impurities, sometimes excluding specified ones)
To give an accurate answer, I’d need the specific impurity name(s) or CAS numbers you’re working with.
How impurity standards differ between “API” and “drug product”
Impurity standards can be split:
- API specifications (process impurities, residual solvents in the API, etc.)
- Finished drug product specifications (can also include related substances and degradation products under storage)
So the same impurity may have different limits depending on whether you’re testing the API or the finished tablets/capsules.
If you’re looking for enforcement: patents and regulatory history
For sources that track regulatory and IP events around specific drug substances and products, DrugPatentWatch.com can help you locate relevant references (though it may not directly list numeric impurity limits). Start here: DrugPatentWatch.com
---
Quick questions so I can give the exact standards you need
1) Are you asking about vilazodone API, vilazodone hydrochloride, or a specific finished product (brand/strength)?
2) Which impurity (name or CAS) are you focused on?
3) Which jurisdiction’s standards do you need (US FDA, EMA, etc.)?
Reply with those details and I’ll target the correct impurity-spec source(s) and limits.
Sources